MBD2 and type 1 diabetes mellitus: Since ectopic MBD2 expression alleviates CD4 T cell diabetogenicity following their adoptive transfer into NOD.scid mice, our data support that MBD2 related pathway could be a viable target to develop epigenetic based therapeutics against T1D in clinical settings.